Dilysmadoc Enterprises Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 4.00 Cr
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -45.43%
- Profit Growth -50.94%
- Ebitda -37.94%
- Net Worth 10.11%
- Total Assets 21.96%
About Dilysmadoc Enterprises
Dilysmadoc Enterprises Private Limited (DEPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2009 and has a history of 16 years and one month. Its registered office is in Navi Mumbai, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srikanth Ramani, Jayashree Ramani, and Neelakantan Ramani serve as directors at the Company.
Company Details
-
Location
Navi Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74990MH2009PTC189373
-
Company No.
189373
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jan 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dilysmadoc Enterprises?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srikanth Ramani
|
Director | 07-Nov-2012 | Current |
|
Jayashree Ramani
|
Director | 06-Jan-2009 | Current |
|
Neelakantan Ramani
|
Director | 06-Jan-2009 | Current |
Financial Performance of Dilysmadoc Enterprises.
Dilysmadoc Enterprises Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.43% decrease. The company also saw a substantial fall in profitability, with a 50.94% decrease in profit. The company's net worth Soared by an impressive increase of 10.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dilysmadoc Enterprises?
In 2023, Dilysmadoc Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dilysmadoc Enterprises?
Unlock and access historical data on people associated with Dilysmadoc Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dilysmadoc Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dilysmadoc Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
